SAH DINAH PH.D. (Chief Scientific Officer) received a stock award from VOYAGER THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/17/2019ACC: 0001104659-19-002348
Officer· Chief Scientific Officer
Since Jan 2019
+75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
18.0%
1/11/2019
138.69K→163.69K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/11/2019 | A · Award | +25K | — | — | 18.0% | 138.69K | 163.69K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
9.10
Held after
50K
Exercisable
—
1/11/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 1/11/2019 | A · Award | +50K | 9.10 | — | 50K |